Alan J. Levy - 22 Oct 2021 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role: Director
Signature: By: Donna Spinola For: Alan J Levy
Issuer symbol: ISRG
Transactions as of: 22 Oct 2021
Net transactions value: -$2,076,927
Form type: 4
Filing time: 26 Oct 2021, 17:07:16 UTC
Previous filing: 26 Jul 2021
Next filing: 26 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISRG	Common Stock	Options Exercise	$213,970	+3,000	+12%	$71.32^*	27,282	22 Oct 2021	Direct	F1, F2
transaction	ISRG	Common Stock	Sale	$1,018,912	-3,000	-11%	$339.64	24,282	22 Oct 2021	Direct	F1, F2, F3
transaction	ISRG	Common Stock	Options Exercise	$256,385	+4,500	+19%	$56.97^*	28,782	22 Oct 2021	Direct	F1, F2
transaction	ISRG	Common Stock	Sale	$1,528,369	-4,500	-16%	$339.64	24,282	22 Oct 2021	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-4,500	-100%	$0.000000^*	0	22 Oct 2021	Common Stock	4,500	$56.97	Direct	F1, F2, F4
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-3,000	-87%	$0.000000	465	22 Oct 2021	Common Stock	3,000	$71.32	Direct	F1, F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 1, 2021.
F2	On October 5, 2021, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price.
F3	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $338.29 to $341.38 as follows: 1,400 shares sold at $338.19 to $338.98; 4,306 shares sold at $339.06 to $339.98; 1,594 shares sold at $340.01 to $340.83; 200 shares sold at $341 to $341.38. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4	Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.
F5	100% of the shares subject to the option shall vest on the earlier of the one year anniversary of the date of grant or the next Annual Meeting of Stockholders, subject to the Reporting Person's continued service as a director to the issuer.